CrossRef The effectiveness and safety of immune checkpoint inhibitors in conversion or neoadjuvant therapy for hepatocellular carcinoma: a meta-analysis and systematic review Lingbo Hu, Yongfu Xu, Yingli Qiao, Aidong Wang, Caidi He, Rongrong Wang BMC Cancer .2025;[Epub] CrossRef Exploring the Potential of CSTF1 as a Prognostic Biomarker in Hepatocellular Carcinoma and Its Correlation with Immune Infiltration Maimaitiming Aimaiti, Dilimulati Maimaitituxun, Xiaokaiti Yilihaer, Talifujiang Kuerban, Junling Zhu, Mieradilijiang Ainiwaer, Zhiqiang Jia, Ainiwaerjiang Abudourousuli Journal of Hepatocellular Carcinoma .2025
VAS were used to assess appetite sensations, and at lunchtime an ad libitum test meal was offered
Will there be horrible adverse side effects that come out later
Patients should avoid self-treating with peptides purchased from unknown suppliers
Contribution of common and rare variants to Asian neovascular age-related macular degeneration subtypes
Who tends to benefit most from l-carnitine Not everyone responds the same